BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

Ramaswamy is now part of Donald Trump’s future Department of Government Efficiency. Learn how he made his fortune and where ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

Acquisition to support the global execution of BioNTech’s oncology strategy and provide full global rights to BNT327/PM8002, an investigational ...

The Karnataka High Court on Wednesday dismissed a petition by Union Bank of India seeking transfer of the investigation of ...